Data for (Study ST000777)

(Analysis AN001228)

Values for each metabolite have been scaled by dividing by the mean across all factors

Run Hierarchial cluster analysis on this study | Run Heatmap cluster analysis on this study

MetaboliteF1F2
Arachidonic acid 0.5425 1.4575
CL 72:7; [M-2H](2-)@9.07 0.9562 1.0438
CL 72:8; [M-2H](2-)@8.88 1.0565 0.9435
CL 78:1; [M-2H](2-)@7.48 0.2452 1.7548
CL 78:5; [M-2H](2-)@6.51 0.6127 1.3873
FFA(16:0) 0.9922 1.0078
FFA(18:0) 0.9825 1.0175
FFA(18:1) 0.8371 1.1629
FFA(18:2) 0.6830 1.3170
FFA(20:0) 0.9892 1.0108
FFA(20:1) 0.8640 1.1360
FFA(20:2) 0.8500 1.1500
FFA(22:0) 0.8913 1.1087
FFA(22:1) 0.8238 1.1762
FFA(22:2) 0.7684 1.2316
FFA(24:0) 0.8934 1.1066
FFA(24:1) 0.7158 1.2842
FFA(24:2) 0.6603 1.3397
lysoPE 18:0; [M-H]-@2.39 0.6894 1.3106
PC 30:1; [M-Ac-H]-@5.54 0.7889 1.2111
PC 32:0; [M-Ac-H]-@6.70 0.7114 1.2886
PC 32:1; [M-Ac-H]-@6.19 0.6941 1.3059
PC 32:2; [M-Ac-H]-@5.67 0.6840 1.3160
PC 34:2; [M-Ac-H]-@6.31 0.7520 1.2480
PC 34:3; [M-Ac-H]-@5.82 0.7362 1.2638
PC 35:4; [M-Ac-H]-@5.95 0.6026 1.3974
PC 36:0; [M-Ac-H]-@8.02 0.6536 1.3464
PC 36:1; [M-Ac-H]-@7.47 0.6677 1.3323
PC 36:2; [M-Ac-H]-@6.96 0.7570 1.2430
PC 36:3; [M-Ac-H]-@6.50 0.7574 1.2426
PC 36:4; [M-Ac-H]-@6.23 0.7089 1.2911
PC 38:2; [M-Ac-H]-@7.60 0.5559 1.4441
PC 38:4; [M-Ac-H]-@6.87 0.7301 1.2699
PC 38:5; [M-Ac-H]-@6.45 0.6385 1.3615
PC 38:6; [M-Ac-H]-@6.05 0.4759 1.5241
PC 40:6; [M-Ac-H]-@6.75 0.3032 1.6968
PE 32:0; [M-H]-@6.72 0.6437 1.3563
PE 32:1; [M-H]-@6.20 0.6245 1.3755
PE 33:0; [M-H]-@7.03 0.9729 1.0271
PE 34:2; [M-H]-@6.38 0.7386 1.2614
PE 34:3; [M-H]-@6.00 0.6125 1.3875
PE 35:0; [M-H]-@7.59 0.6610 1.3390
PE 35:2; [M-H]-@6.70 0.8756 1.1244
PE 36:0; [M-H]-@7.87 0.8104 1.1896
PE 36:1; [M-H]-@7.44 0.6948 1.3052
PE 36:3; [M-H]-@6.54 0.7154 1.2846
PE 36:4; [M-H]-@6.25 0.6602 1.3398
PE 38:6; [M-H]-@6.12 0.5276 1.4724
PE 40:3; [M-H]-@7.22 0.6393 1.3607
PE 40:7; [M-H]-@6.37 0.5511 1.4489
PG 33:0; [M-H]-@6.00 0.7458 1.2542
PG 36:0; [M-H]-@6.81 1.0364 0.9636
PG 36:2; [M-H]-@5.71 0.5180 1.4820
PG 36:3; [M-H]-@5.15 0.3569 1.6431
PG 38:2; [M-H]-@6.07 0.5217 1.4783
PG 38:5; [M-H]-@5.07 0.2486 1.7514
PI 34:1; [M-H]-@5.59 0.6250 1.3750
PI 36:4; [M-H]-@5.12 0.7301 1.2699
PI 38:4; [M-H]-@5.73 0.7222 1.2778
PI 38:5; [M-H]-@5.28 0.7955 1.2045
PI 39:4; [M-H]-@6.08 0.4851 1.5149
plasmenyl-PE 32:0; [M-H]-@7.08 0.6851 1.3149
plasmenyl-PE 34:2; [M-H]-@6.69 0.7795 1.2205
plasmenyl-PE 36:2; [M-H]-@7.28 0.7812 1.2188
plasmenyl-PE 36:3; [M-H]-@6.89 0.7363 1.2637
plasmenyl-PE 38:1; [M-H]-@8.24 0.4409 1.5591
plasmenyl-PE 38:4; [M-H]-@7.21 0.6842 1.3158
plasmenyl-PE 38:5; [M-H]-@6.71 0.6942 1.3058
plasmenyl-PE 38:6; [M-H]-@6.57 0.5093 1.4907
plasmenyl-PE 40:4; [M-H]-@7.73 0.5086 1.4914
plasmenyl-PE 40:5; [M-H]-@7.39 0.6247 1.3753
PS 34:1; [M-H]-@5.75 0.6364 1.3636
PS 34:2; [M-H]-@5.27 0.6679 1.3321
PS 36:2; [M-H]-@5.95 0.5129 1.4871
PS 38:4; [M-H]-@5.91 0.4803 1.5197
PS 40:5; [M-H]-@6.02 0.6192 1.3808
Run Hierarchial cluster analysis on this study | Run Heatmap cluster analysis on this study

Factors:

F1Exercise:POST
F2Exercise:PRE
  logo